Yahoo Web Search

Search results

    • FDA Roundup: April 26, 2024

      WKRN Nashville· 6 hours ago

      This represents the first FDA approval of a systemic therapy for the treatment of patients with pediatric LGG with BRAF rearrangements, including fusions. Full prescribing ...

    • Small Business - Shelby County Reporter | Shelby County Reporter

      The Shelby County Reporter· 2 days ago

      Stargardt Disease Market to Grow Rapidly at a CAGR of 32% by 2034 | DelveInsight PR Newswire LAS VEGAS, April 24, 2024 The expected launch of potential therapies may increase the Stargardt disease market size in the coming years, assisted by an